185 related articles for article (PubMed ID: 37980400)
1. Design and evaluation of tadpole-like conformational antimicrobial peptides.
Tang Z; Jiang W; Li S; Huang X; Yang Y; Chen X; Qiu J; Xiao C; Xie Y; Zhang X; Li J; Verma CS; He Y; Yang A
Commun Biol; 2023 Nov; 6(1):1177. PubMed ID: 37980400
[TBL] [Abstract][Full Text] [Related]
2. Disulfide engineering on temporin-SHf: Stabilizing the bioactive conformation of an ultra-short antimicrobial peptide.
Dolle A; Nagati VB; Hunashal Y; Krishnamurthy K; Pasupulati AK; Raghothama S; Gowd KH
Chem Biol Drug Des; 2019 Sep; 94(3):1634-1646. PubMed ID: 30924306
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity.
André S; Washington SK; Darby E; Vega MM; Filip AD; Ash NS; Muzikar KA; Piesse C; Foulon T; O'Leary DJ; Ladram A
ACS Chem Biol; 2015 Oct; 10(10):2257-66. PubMed ID: 26181487
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a Novel Antimicrobial Peptide, Temporin-PKE, from the Skin Secretion of
Lin Y; Jiang Y; Zhao Z; Lu Y; Xi X; Ma C; Chen X; Zhou M; Chen T; Shaw C; Wang L
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740884
[TBL] [Abstract][Full Text] [Related]
5. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.
Abbassi F; Lequin O; Piesse C; Goasdoué N; Foulon T; Nicolas P; Ladram A
J Biol Chem; 2010 May; 285(22):16880-92. PubMed ID: 20308076
[TBL] [Abstract][Full Text] [Related]
6. Membrane mechanism of temporin-1CEc, an antimicrobial peptide isolated from the skin secretions of Rana chensinensis, and its systemic analogs.
Ji F; Zhao Y; Jiang F; Shang D
Bioorg Chem; 2022 Feb; 119():105544. PubMed ID: 34953322
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
Raguse TL; Porter EA; Weisblum B; Gellman SH
J Am Chem Soc; 2002 Oct; 124(43):12774-85. PubMed ID: 12392424
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationship Study of Helix-Stabilized Antimicrobial Peptides Containing Nonproteinogenic Amino Acids.
Ito T; Hashimoto W; Ohoka N; Misawa T; Inoue T; Kawano R; Demizu Y
ACS Biomater Sci Eng; 2023 Aug; 9(8):4654-4661. PubMed ID: 37486982
[TBL] [Abstract][Full Text] [Related]
9. New insight into the mechanism of action of the temporin antimicrobial peptides.
Saviello MR; Malfi S; Campiglia P; Cavalli A; Grieco P; Novellino E; Carotenuto A
Biochemistry; 2010 Feb; 49(7):1477-85. PubMed ID: 20082523
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.
Kim SJ; Kim JS; Lee YS; Sim DW; Lee SH; Bahk YY; Lee KH; Kim EH; Park SJ; Lee BJ; Won HS
Molecules; 2013 Jan; 18(1):859-76. PubMed ID: 23344198
[TBL] [Abstract][Full Text] [Related]
11. Rational design of alpha-helical antimicrobial peptide with Val and Arg residues.
Ma Q; Dong N; Cao Y; Shan A
Wei Sheng Wu Xue Bao; 2011 Mar; 51(3):346-51. PubMed ID: 21598838
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Structure-Function Relationship Unveils Salt-Resistant Mode of Action of a Potent MRSA-Inhibiting Antimicrobial Peptide, RR14.
Kao CC; Lin TL; Lin CJ; Tseng TS
J Bacteriol; 2022 Dec; 204(12):e0031222. PubMed ID: 36377870
[TBL] [Abstract][Full Text] [Related]
13. Functional and Toxicological Evaluation of MAA-41: A Novel Rationally Designed Antimicrobial Peptide Using Hybridization and Modification Methods from LL-37 and BMAP-28.
Masadeh M; Ayyad A; Haddad R; Alsaggar M; Alzoubi K; Alrabadi N
Curr Pharm Des; 2022; 28(26):2177-2188. PubMed ID: 35792128
[TBL] [Abstract][Full Text] [Related]
14. Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs.
Monincová L; Budesínský M; Slaninová J; Hovorka O; Cvacka J; Voburka Z; Fucík V; Borovicková L; Bednárová L; Straka J; Cerovský V
Amino Acids; 2010 Aug; 39(3):763-75. PubMed ID: 20198492
[TBL] [Abstract][Full Text] [Related]
15. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
[TBL] [Abstract][Full Text] [Related]
16. The design of cell-selective tryptophan and arginine-rich antimicrobial peptides by introducing hydrophilic uncharged residues.
Zhu Y; Akhtar MU; Li B; Chou S; Shao C; Li J; Shan A
Acta Biomater; 2022 Nov; 153():557-572. PubMed ID: 36115654
[TBL] [Abstract][Full Text] [Related]
17. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions.
Zelezetsky I; Pag U; Sahl HG; Tossi A
Peptides; 2005 Dec; 26(12):2368-76. PubMed ID: 15939509
[TBL] [Abstract][Full Text] [Related]
18. De novo design of potent antimicrobial peptides.
Frecer V; Ho B; Ding JL
Antimicrob Agents Chemother; 2004 Sep; 48(9):3349-57. PubMed ID: 15328096
[TBL] [Abstract][Full Text] [Related]
19. Design of model amphipathic peptides having potent antimicrobial activities.
Blondelle SE; Houghten RA
Biochemistry; 1992 Dec; 31(50):12688-94. PubMed ID: 1472506
[TBL] [Abstract][Full Text] [Related]
20. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
